You have 9 free searches left this month | for more free features.

Catecholamines

Showing 1 - 25 of 731

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Fetal Bradycardia, Hypertonic Uterine, Catecholamines Trial in São Paulo (Epidural bupivacaine with vasoconstrictor 0.125%,

Completed
  • Fetal Bradycardia
  • +2 more
  • Epidural bupivacaine with vasoconstrictor 0.125%
  • +6 more
  • São Paulo, Brazil
    Shirley Andrade Santos
Mar 4, 2022

Dysglycemia in Pheochromocytoma and Paraganglioma

Active, not recruiting
  • Pheochromocytoma
  • Paraganglioma
  • Catecholamines
  • Beijing, Beijing, China
    Xian-Liang Zhou
Jul 9, 2022

Vitiligo Patients Before and After Excimer Light

Not yet recruiting
  • Vitiligo, Generalized
  • serum and urinary catecholamines
  • (no location specified)
Mar 16, 2021

Development of Myocardial Depression in Acute Neurological

Recruiting
  • Myocardial Depression
  • +3 more
    • Columbus, Ohio
      The Ohio Sate University
    May 24, 2022

    Pheochromocytoma, Endocrine Disease, Endocrine Diseases Trial run by the Eunice Kennedy Shriver National Institute of Child

    Recruiting
    • Pheochromocytoma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 18, 2023

    Cardiac Output, Low, Cardiac Output, High, Perfusion; Complications Trial (Epinephrin, Norepinephrine, Phenylephrine)

    Not yet recruiting
    • Cardiac Output, Low
    • +2 more
    • (no location specified)
    Aug 5, 2022

    Pheochromocytoma Trial in Seoul (dexmedetomidine, 0.9% normal saline)

    Completed
    • Pheochromocytoma
    • Seoul, Korea, Republic of
      Severance hospital
    Sep 12, 2023

    Anaesthesia During Interventional Mitral Valve Repair

    Completed
    • Blood Pressure
    • Hypotension Drug-Induced
    • Heidelberg, Baden-Würtemberg, Germany
      Anästhesiologische Klinik (Universitätsklinikum Heidelberg)
    Oct 25, 2021

    Shock, Cardiogenic, Extra-Corporeal-Life-Support ( ECLS), Autonomic Nervous System Diseases Trial in Nancy (Biological)

    Recruiting
    • Shock, Cardiogenic
    • +3 more
    • Biological
    • Nancy, France
      CHRU Nancy
    Feb 24, 2022

    Hypertension, Cardiovascular Risk Factor Trial in Taipei (Resistance exercise training)

    Completed
    • Hypertension
    • Cardiovascular Risk Factor
    • Resistance exercise training
    • Taipei, Taiwan
      National Taiwan University
    Dec 21, 2022

    Blood Pressure, Low Back Pain, Hypertension Trial in Birmingham (Permanent Epidural Spinal Cord Stimulation)

    Active, not recruiting
    • Blood Pressure
    • +2 more
    • Permanent Epidural Spinal Cord Stimulation
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Sep 23, 2022

    Shock Trial (increase of mean arterial pressure at 65-70 mmHg, increase of mean arterial pressure at 80-85 mmHg)

    Not yet recruiting
    • Shock
    • increase of mean arterial pressure at 65-70 mmHg
    • increase of mean arterial pressure at 80-85 mmHg
    • (no location specified)
    Dec 14, 2022

    Obesity Trial in La Jolla (Standard of Care, Time Restricted Eating)

    Recruiting
    • Obesity
    • Standard of Care
    • Time Restricted Eating
    • La Jolla, California
      Altman Clinical and Translational Research Institute
    Jan 27, 2023

    Paraganglioma, Pheochromocytoma Trial in New York, Cleveland (Lanreotide)

    Recruiting
    • Paraganglioma
    • Pheochromocytoma
    • New York, New York
    • +1 more
    Oct 5, 2022

    Septic Shock Trial in Angers (increase of mean arterial pressure at 80-85 mmHg., increase of mean arterial pressure at 65-70

    Recruiting
    • Septic Shock
    • increase of mean arterial pressure at 80-85 mmHg.
    • increase of mean arterial pressure at 65-70 mmHg.
    • Angers, France
      CHU Angers. Médecine Intensive Réanimation et médecine hyperbare
    Oct 30, 2022

    Arrest, Bone, Development Trial in Lahore (Propranolol, Nandrolone Decanoate)

    Recruiting
    • Arrest
    • +3 more
    • Lahore, Punjab, Pakistan
      King Edward Medical University, Mayo Hospital
    Mar 27, 2023

    Sleep Apnea, Obstructive, Endothelial Dysfunction Trial in Angers (Mandibular advancement device treatment)

    Not yet recruiting
    • Sleep Apnea, Obstructive
    • Endothelial Dysfunction
    • Mandibular advancement device treatment
    • Angers, France
      Angers University Hospital
    Jun 30, 2023

    Acute Cardiac Dysfunction in Critical Illnes

    Not yet recruiting
    • Multi Organ Failure
    • +5 more
    • Echocardiography
    • +2 more
    • (no location specified)
    May 16, 2023

    Arrythmia, Pain, Acute Trial in Assiut (right stellate ganglion block)

    Recruiting
    • Arrythmia
    • Pain, Acute
    • right stellate ganglion block
    • Assiut, Egypt
      Emad Zarief Kamel Said
    Jun 30, 2022

    Septic Shock, Acute Kidney Injury Trial in Lexington (Standard of Care, Angiotensin II)

    Recruiting
    • Septic Shock
    • Acute Kidney Injury
    • Standard of Care
    • Angiotensin II
    • Lexington, Kentucky
      University of Kentucky HealthCare Chandler Medical Center
    Dec 7, 2022

    Metabolic Myopathy in Endocrinopathy

    Not yet recruiting
    • Cushing Syndrome
    • +3 more
    • Muscle biopsy
    • (no location specified)
    Jul 12, 2022

    Disorder of Consciousness Trial (Ventriculoperitoneal shunt)

    Recruiting
    • Disorder of Consciousness
    • Ventriculoperitoneal shunt
    • Toulouse, France
      Eric SCHMIDT
    Nov 16, 2022

    Biomarkers of Risk of Parkinson Disease

    Active, not recruiting
    • Parkinson Disease
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 13, 2023

    Healthy Trial in Kaunas (Heat therapy)

    Completed
    • Healthy
    • Heat therapy
    • Kaunas, Lithuania
      Institute of Sport Science and Innovations
    Nov 17, 2023

    Resistant Hypertension Trial (SAAE, traditional triple antihypertensive treatment)

    Not yet recruiting
    • Resistant Hypertension
    • SAAE
    • traditional triple antihypertensive treatment
    • (no location specified)
    Sep 20, 2022